Patents by Inventor Edmond Weisbart

Edmond Weisbart has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Identification of specialty drugs
    Patent number: 8160898
    Abstract: Methods for determining whether a drug is a specialty drug, methods for creating tools to be used in making the determination, and the tools themselves are disclosed. The overall value of a drug depends on the drug's attribute values with respect to each of a set of drug attributes (concerning, e.g., the drug's route of administration, targeted disease, possible adverse reactions, risk of toxicity, cost, need for patient compliance with the treatment regime, and handling, preparation, and/or storage requirements. If the overall value or its partial overall values meet certain criteria, the drug is deemed to be a specialty drug.
    Type: Grant
    Filed: August 25, 2011
    Date of Patent: April 17, 2012
    Assignee: Express Scripts, Inc.
    Inventors: Edmond Weisbart, Andrew Behm, Aimee Tharaldson, Steven Miller
  • IDENTIFICATION OF SPECIALTY DRUGS
    Publication number: 20120084097
    Abstract: Methods for determining whether a drug is a specialty drug, methods for creating tools to be used in making the determination, and the tools themselves are disclosed. The overall value of a drug depends on the drug's attribute values with respect to each of a set of drug attributes (concerning, e.g., the drug's route of administration, targeted disease, possible adverse reactions, risk of toxicity, cost, need for patient compliance with the treatment regime, and handling, preparation, and/or storage requirements. If the overall value or its partial overall values meet certain criteria, the drug is deemed to be a specialty drug.
    Type: Application
    Filed: December 13, 2011
    Publication date: April 5, 2012
    Applicant: EXPRESS SCRIPTS, INC.
    Inventors: Edmond WEISBART, Andrew BEHM, Aimee THARALDSON, Steven MILLER
  • IDENTIFICATION OF SPECIALTY DRUGS
    Publication number: 20110307271
    Abstract: Methods for determining whether a drug is a specialty drug, methods for creating tools to be used in making the determination, and the tools themselves are disclosed. The overall value of a drug depends on the drug's attribute values with respect to each of a set of drug attributes (concerning, e.g., the drug's route of administration, targeted disease, possible adverse reactions, risk of toxicity, cost, need for patient compliance with the treatment regime, and handling, preparation, and/or storage requirements. If the overall value or its partial overall values meet certain criteria, the drug is deemed to be a specialty drug.
    Type: Application
    Filed: August 25, 2011
    Publication date: December 15, 2011
    Applicant: Express Scripts, Inc.
    Inventors: Edmond Weisbart, Andrew Behm, Aimee Tharaldson, Steven Miller
  • Identification of specialty drugs
    Patent number: 8050940
    Abstract: Methods for determining whether a drug is a specialty drug, methods for creating tools to be used in making the determination, and the tools themselves are disclosed. The overall value of a drug depends on the drug's attribute values with respect to each of a set of drug attributes (concerning, e.g., the drug's route of administration, targeted disease, possible adverse reactions, risk of toxicity, cost, need for patient compliance with the treatment regime, and handling, preparation, and/or storage requirements. If the overall value or its partial overall values meet certain criteria, the drug is deemed to be a specialty drug.
    Type: Grant
    Filed: January 28, 2008
    Date of Patent: November 1, 2011
    Assignee: Express Scripts, Inc.
    Inventors: Edmond Weisbart, Andrew Behm, Aimee Tharaldson, Steven Miller
  • Identification of specialty drugs
    Publication number: 20090192807
    Abstract: Methods for determining whether a drug is a specialty drug, methods for creating tools to be used in making the determination, and the tools themselves are disclosed. The overall value of a drug depends on the drug's attribute values with respect to each of a set of drug attributes (concerning, e.g., the drug's route of administration, targeted disease, possible adverse reactions, risk of toxicity, cost, need for patient compliance with the treatment regime, and handling, preparation, and/or storage requirements. If the overall value or its partial overall values meet certain criteria, the drug is deemed to be a specialty drug.
    Type: Application
    Filed: January 28, 2008
    Publication date: July 30, 2009
    Applicant: Express Scripts, Inc.
    Inventors: Edmond Weisbart, Andrew Behm, Aimee Tharaldson, Steven Miller